“…The use of pathology review for other cancers, including gynecologic cancers, 7-10 testicular cancer, 11 prostate cancer, 12,13 bladder cancer, 14 lymphoma, 15 and sarcoma, 16,17 in contrast, has been repeatedly examined and justified. Interestingly, the percentage of significantly changed diagnoses reviewing these cancers ranges anywhere from 1.3% 13 to 38%.…”